nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—Cytochrome P450 3A4 Inhibitors—Cyclosporine—rheumatoid arthritis	0.372	1	CiPCiCtD
Pazopanib—PIP4K2C—rheumatoid arthritis	0.18	0.597	CbGaD
Pazopanib—SH2B3—rheumatoid arthritis	0.121	0.403	CbGaD
Pazopanib—SLCO1B1—Penicillamine—rheumatoid arthritis	0.0527	0.314	CbGbCtD
Pazopanib—ABCG2—Leflunomide—rheumatoid arthritis	0.0132	0.0786	CbGbCtD
Pazopanib—SLCO1B1—Sulfasalazine—rheumatoid arthritis	0.0102	0.0611	CbGbCtD
Pazopanib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.00814	0.0485	CbGbCtD
Pazopanib—SLCO1B1—Cyclosporine—rheumatoid arthritis	0.00777	0.0463	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.00653	0.039	CbGbCtD
Pazopanib—ABCG2—Cyclosporine—rheumatoid arthritis	0.00617	0.0368	CbGbCtD
Pazopanib—CYP1A2—Leflunomide—rheumatoid arthritis	0.00543	0.0324	CbGbCtD
Pazopanib—SLCO1B1—Methotrexate—rheumatoid arthritis	0.00411	0.0245	CbGbCtD
Pazopanib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00406	0.0242	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00387	0.0231	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—rheumatoid arthritis	0.00348	0.0208	CbGbCtD
Pazopanib—CYP2C8—Cyclosporine—rheumatoid arthritis	0.00329	0.0196	CbGbCtD
Pazopanib—ABCG2—Methotrexate—rheumatoid arthritis	0.00327	0.0195	CbGbCtD
Pazopanib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00315	0.0188	CbGbCtD
Pazopanib—ABCB1—Betamethasone—rheumatoid arthritis	0.00252	0.015	CbGbCtD
Pazopanib—ABCB1—Prednisolone—rheumatoid arthritis	0.00248	0.0148	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.00236	0.014	CbGbCtD
Pazopanib—ABCB1—Prednisone—rheumatoid arthritis	0.00235	0.014	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00232	0.0138	CbGbCtD
Pazopanib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00222	0.0133	CbGbCtD
Pazopanib—CYP2C8—Dexamethasone—rheumatoid arthritis	0.00216	0.0129	CbGbCtD
Pazopanib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.0021	0.0125	CbGbCtD
Pazopanib—FGFR3—cartilage tissue—rheumatoid arthritis	0.0018	0.0708	CbGeAlD
Pazopanib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00176	0.0105	CbGbCtD
Pazopanib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00151	0.009	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00149	0.00888	CbGbCtD
Pazopanib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00146	0.00873	CbGbCtD
Pazopanib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00141	0.00842	CbGbCtD
Pazopanib—CYP3A4—Prednisone—rheumatoid arthritis	0.00141	0.00838	CbGbCtD
Pazopanib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.00138	0.00823	CbGbCtD
Pazopanib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00133	0.00795	CbGbCtD
Pazopanib—FGF1—cartilage tissue—rheumatoid arthritis	0.00125	0.0491	CbGeAlD
Pazopanib—ABCB1—Methotrexate—rheumatoid arthritis	0.00118	0.00702	CbGbCtD
Pazopanib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.000878	0.00523	CbGbCtD
Pazopanib—FGFR2—exocrine gland—rheumatoid arthritis	0.000639	0.0252	CbGeAlD
Pazopanib—MAP3K9—digestive system—rheumatoid arthritis	0.000546	0.0215	CbGeAlD
Pazopanib—RIOK2—parotid gland—rheumatoid arthritis	0.000508	0.02	CbGeAlD
Pazopanib—ITK—lymphoid tissue—rheumatoid arthritis	0.000456	0.0179	CbGeAlD
Pazopanib—LYN—connective tissue—rheumatoid arthritis	0.00045	0.0177	CbGeAlD
Pazopanib—PI4KB—parotid gland—rheumatoid arthritis	0.00045	0.0177	CbGeAlD
Pazopanib—FGFR3—connective tissue—rheumatoid arthritis	0.000447	0.0176	CbGeAlD
Pazopanib—KIT—exocrine gland—rheumatoid arthritis	0.000444	0.0175	CbGeAlD
Pazopanib—PI4KB—saliva-secreting gland—rheumatoid arthritis	0.000431	0.017	CbGeAlD
Pazopanib—PIP4K2C—parotid gland—rheumatoid arthritis	0.000395	0.0155	CbGeAlD
Pazopanib—SH2B3—lymphoid tissue—rheumatoid arthritis	0.000391	0.0154	CbGeAlD
Pazopanib—PIP4K2C—saliva-secreting gland—rheumatoid arthritis	0.000378	0.0149	CbGeAlD
Pazopanib—SH2B3—tendon—rheumatoid arthritis	0.000367	0.0145	CbGeAlD
Pazopanib—AURKC—tendon—rheumatoid arthritis	0.000362	0.0142	CbGeAlD
Pazopanib—PLK4—lymphoid tissue—rheumatoid arthritis	0.000352	0.0138	CbGeAlD
Pazopanib—STK16—lymphoid tissue—rheumatoid arthritis	0.000332	0.0131	CbGeAlD
Pazopanib—MAP3K2—connective tissue—rheumatoid arthritis	0.000329	0.013	CbGeAlD
Pazopanib—LYN—lymphoid tissue—rheumatoid arthritis	0.000329	0.0129	CbGeAlD
Pazopanib—STK16—digestive system—rheumatoid arthritis	0.000328	0.0129	CbGeAlD
Pazopanib—FGFR2—saliva-secreting gland—rheumatoid arthritis	0.000319	0.0125	CbGeAlD
Pazopanib—STK16—tendon—rheumatoid arthritis	0.000312	0.0123	CbGeAlD
Pazopanib—FGF1—connective tissue—rheumatoid arthritis	0.00031	0.0122	CbGeAlD
Pazopanib—FLT1—parotid gland—rheumatoid arthritis	0.000308	0.0121	CbGeAlD
Pazopanib—RIOK2—tendon—rheumatoid arthritis	0.000308	0.0121	CbGeAlD
Pazopanib—EPHB6—parotid gland—rheumatoid arthritis	0.000305	0.012	CbGeAlD
Pazopanib—FLT1—saliva-secreting gland—rheumatoid arthritis	0.000295	0.0116	CbGeAlD
Pazopanib—FGFR2—connective tissue—rheumatoid arthritis	0.000293	0.0115	CbGeAlD
Pazopanib—EPHB6—saliva-secreting gland—rheumatoid arthritis	0.000292	0.0115	CbGeAlD
Pazopanib—TAOK3—parotid gland—rheumatoid arthritis	0.000291	0.0114	CbGeAlD
Pazopanib—LIMK2—lymphoid tissue—rheumatoid arthritis	0.000284	0.0112	CbGeAlD
Pazopanib—TAOK3—saliva-secreting gland—rheumatoid arthritis	0.000279	0.011	CbGeAlD
Pazopanib—STK36—tendon—rheumatoid arthritis	0.000276	0.0109	CbGeAlD
Pazopanib—PI4KB—tendon—rheumatoid arthritis	0.000272	0.0107	CbGeAlD
Pazopanib—FLT1—connective tissue—rheumatoid arthritis	0.000271	0.0107	CbGeAlD
Pazopanib—KDR—parotid gland—rheumatoid arthritis	0.000261	0.0103	CbGeAlD
Pazopanib—MAP2K5—parotid gland—rheumatoid arthritis	0.000261	0.0103	CbGeAlD
Pazopanib—TAOK3—connective tissue—rheumatoid arthritis	0.000256	0.0101	CbGeAlD
Pazopanib—FLT4—lymphoid tissue—rheumatoid arthritis	0.000255	0.01	CbGeAlD
Pazopanib—PDGFRA—connective tissue—rheumatoid arthritis	0.000254	0.01	CbGeAlD
Pazopanib—KDR—saliva-secreting gland—rheumatoid arthritis	0.00025	0.00983	CbGeAlD
Pazopanib—MAP2K5—saliva-secreting gland—rheumatoid arthritis	0.00025	0.00983	CbGeAlD
Pazopanib—MAP3K2—lymphoid tissue—rheumatoid arthritis	0.000241	0.00947	CbGeAlD
Pazopanib—PIP4K2C—tendon—rheumatoid arthritis	0.000239	0.00939	CbGeAlD
Pazopanib—FGFR1—tendon—rheumatoid arthritis	0.000237	0.00932	CbGeAlD
Pazopanib—KIT—parotid gland—rheumatoid arthritis	0.000231	0.00909	CbGeAlD
Pazopanib—KDR—connective tissue—rheumatoid arthritis	0.000229	0.00903	CbGeAlD
Pazopanib—FGF1—lymphoid tissue—rheumatoid arthritis	0.000227	0.00892	CbGeAlD
Pazopanib—PDGFRB—parotid gland—rheumatoid arthritis	0.000226	0.00888	CbGeAlD
Pazopanib—FGF1—digestive system—rheumatoid arthritis	0.000224	0.00882	CbGeAlD
Pazopanib—CSF1R—connective tissue—rheumatoid arthritis	0.000224	0.00881	CbGeAlD
Pazopanib—KIT—saliva-secreting gland—rheumatoid arthritis	0.000221	0.00871	CbGeAlD
Pazopanib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	0.000216	0.00851	CbGeAlD
Pazopanib—FGFR2—digestive system—rheumatoid arthritis	0.000212	0.00833	CbGeAlD
Pazopanib—KIT—connective tissue—rheumatoid arthritis	0.000203	0.008	CbGeAlD
Pazopanib—PDGFRB—connective tissue—rheumatoid arthritis	0.000199	0.00782	CbGeAlD
Pazopanib—FLT1—lymphoid tissue—rheumatoid arthritis	0.000198	0.00781	CbGeAlD
Pazopanib—FLT1—digestive system—rheumatoid arthritis	0.000196	0.00772	CbGeAlD
Pazopanib—STK10—lymphoid tissue—rheumatoid arthritis	0.000188	0.0074	CbGeAlD
Pazopanib—TAOK3—lymphoid tissue—rheumatoid arthritis	0.000187	0.00737	CbGeAlD
Pazopanib—FLT1—tendon—rheumatoid arthritis	0.000187	0.00734	CbGeAlD
Pazopanib—PDGFRA—lymphoid tissue—rheumatoid arthritis	0.000186	0.00732	CbGeAlD
Pazopanib—STK10—digestive system—rheumatoid arthritis	0.000186	0.0073	CbGeAlD
Pazopanib—TAOK3—digestive system—rheumatoid arthritis	0.000185	0.00728	CbGeAlD
Pazopanib—EPHB6—tendon—rheumatoid arthritis	0.000184	0.00726	CbGeAlD
Pazopanib—PDGFRA—digestive system—rheumatoid arthritis	0.000184	0.00723	CbGeAlD
Pazopanib—STK10—tendon—rheumatoid arthritis	0.000177	0.00695	CbGeAlD
Pazopanib—TAOK3—tendon—rheumatoid arthritis	0.000176	0.00693	CbGeAlD
Pazopanib—UGT1A1—digestive system—rheumatoid arthritis	0.000175	0.0069	CbGeAlD
Pazopanib—PDGFRA—tendon—rheumatoid arthritis	0.000175	0.00688	CbGeAlD
Pazopanib—KDR—lymphoid tissue—rheumatoid arthritis	0.000168	0.0066	CbGeAlD
Pazopanib—KDR—digestive system—rheumatoid arthritis	0.000166	0.00652	CbGeAlD
Pazopanib—CSF1R—lymphoid tissue—rheumatoid arthritis	0.000164	0.00645	CbGeAlD
Pazopanib—CSF1R—digestive system—rheumatoid arthritis	0.000162	0.00637	CbGeAlD
Pazopanib—KDR—tendon—rheumatoid arthritis	0.000158	0.00621	CbGeAlD
Pazopanib—MAP2K5—tendon—rheumatoid arthritis	0.000158	0.00621	CbGeAlD
Pazopanib—CSF1R—tendon—rheumatoid arthritis	0.000154	0.00606	CbGeAlD
Pazopanib—KIT—lymphoid tissue—rheumatoid arthritis	0.000149	0.00585	CbGeAlD
Pazopanib—KIT—digestive system—rheumatoid arthritis	0.000147	0.00578	CbGeAlD
Pazopanib—SLCO1B1—digestive system—rheumatoid arthritis	0.000146	0.00574	CbGeAlD
Pazopanib—PDGFRB—lymphoid tissue—rheumatoid arthritis	0.000145	0.00572	CbGeAlD
Pazopanib—PDGFRB—digestive system—rheumatoid arthritis	0.000143	0.00565	CbGeAlD
Pazopanib—PDGFRB—tendon—rheumatoid arthritis	0.000137	0.00537	CbGeAlD
Pazopanib—ABCG2—parotid gland—rheumatoid arthritis	0.000127	0.00499	CbGeAlD
Pazopanib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000121	0.00478	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—rheumatoid arthritis	0.000109	0.0912	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—rheumatoid arthritis	0.000109	0.0912	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—rheumatoid arthritis	0.000103	0.0861	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—rheumatoid arthritis	0.000103	0.0861	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Dexamethasone—rheumatoid arthritis	0.000101	0.0847	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Betamethasone—rheumatoid arthritis	0.000101	0.0847	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Triamcinolone—rheumatoid arthritis	9.86e-05	0.0828	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Triamcinolone—rheumatoid arthritis	9.86e-05	0.0828	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisone—rheumatoid arthritis	9.36e-05	0.0786	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisone—rheumatoid arthritis	9.36e-05	0.0786	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—rheumatoid arthritis	9.13e-05	0.0767	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisolone—rheumatoid arthritis	9.13e-05	0.0767	CbGdCrCtD
Pazopanib—CYP1A2—digestive system—rheumatoid arthritis	7.76e-05	0.00305	CbGeAlD
Pazopanib—CYP3A4—digestive system—rheumatoid arthritis	5.62e-05	0.00221	CbGeAlD
Pazopanib—CYP2D6—digestive system—rheumatoid arthritis	5.53e-05	0.00218	CbGeAlD
Pazopanib—ABCB1—lymphoid tissue—rheumatoid arthritis	4.03e-05	0.00158	CbGeAlD
Pazopanib—ABCB1—digestive system—rheumatoid arthritis	3.98e-05	0.00156	CbGeAlD
Pazopanib—Decreased appetite—Cyclosporine—rheumatoid arthritis	3.31e-05	0.000593	CcSEcCtD
Pazopanib—Infestation NOS—Methotrexate—rheumatoid arthritis	3.3e-05	0.000591	CcSEcCtD
Pazopanib—Infestation—Methotrexate—rheumatoid arthritis	3.3e-05	0.000591	CcSEcCtD
Pazopanib—Rash—Azathioprine—rheumatoid arthritis	3.3e-05	0.00059	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—rheumatoid arthritis	3.3e-05	0.00059	CcSEcCtD
Pazopanib—Dermatitis—Azathioprine—rheumatoid arthritis	3.29e-05	0.000589	CcSEcCtD
Pazopanib—Flushing—Prednisone—rheumatoid arthritis	3.29e-05	0.000589	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Cyclosporine—rheumatoid arthritis	3.29e-05	0.000589	CcSEcCtD
Pazopanib—Skin disorder—Hydrocortisone—rheumatoid arthritis	3.29e-05	0.000588	CcSEcCtD
Pazopanib—Fatigue—Cyclosporine—rheumatoid arthritis	3.28e-05	0.000588	CcSEcCtD
Pazopanib—Headache—Azathioprine—rheumatoid arthritis	3.27e-05	0.000586	CcSEcCtD
Pazopanib—Hyperhidrosis—Hydrocortisone—rheumatoid arthritis	3.27e-05	0.000586	CcSEcCtD
Pazopanib—Dizziness—Leflunomide—rheumatoid arthritis	3.26e-05	0.000584	CcSEcCtD
Pazopanib—Pain—Cyclosporine—rheumatoid arthritis	3.26e-05	0.000583	CcSEcCtD
Pazopanib—Dry mouth—Triamcinolone—rheumatoid arthritis	3.25e-05	0.000582	CcSEcCtD
Pazopanib—Anorexia—Hydrocortisone—rheumatoid arthritis	3.23e-05	0.000578	CcSEcCtD
Pazopanib—Stomatitis—Methotrexate—rheumatoid arthritis	3.22e-05	0.000576	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—rheumatoid arthritis	3.22e-05	0.000576	CcSEcCtD
Pazopanib—Oedema—Triamcinolone—rheumatoid arthritis	3.19e-05	0.00057	CcSEcCtD
Pazopanib—Syncope—Betamethasone—rheumatoid arthritis	3.18e-05	0.000569	CcSEcCtD
Pazopanib—Syncope—Dexamethasone—rheumatoid arthritis	3.18e-05	0.000569	CcSEcCtD
Pazopanib—Infection—Triamcinolone—rheumatoid arthritis	3.17e-05	0.000567	CcSEcCtD
Pazopanib—Infection—Methylprednisolone—rheumatoid arthritis	3.16e-05	0.000565	CcSEcCtD
Pazopanib—Haematuria—Methotrexate—rheumatoid arthritis	3.15e-05	0.000563	CcSEcCtD
Pazopanib—Vomiting—Leflunomide—rheumatoid arthritis	3.14e-05	0.000562	CcSEcCtD
Pazopanib—Shock—Triamcinolone—rheumatoid arthritis	3.14e-05	0.000561	CcSEcCtD
Pazopanib—Insomnia—Prednisolone—rheumatoid arthritis	3.14e-05	0.000561	CcSEcCtD
Pazopanib—Alopecia—Prednisone—rheumatoid arthritis	3.13e-05	0.000561	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—rheumatoid arthritis	3.13e-05	0.00056	CcSEcCtD
Pazopanib—Hepatobiliary disease—Methotrexate—rheumatoid arthritis	3.12e-05	0.000559	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—rheumatoid arthritis	3.12e-05	0.000558	CcSEcCtD
Pazopanib—Gastrointestinal pain—Cyclosporine—rheumatoid arthritis	3.12e-05	0.000557	CcSEcCtD
Pazopanib—Loss of consciousness—Betamethasone—rheumatoid arthritis	3.12e-05	0.000557	CcSEcCtD
Pazopanib—Loss of consciousness—Dexamethasone—rheumatoid arthritis	3.12e-05	0.000557	CcSEcCtD
Pazopanib—Epistaxis—Methotrexate—rheumatoid arthritis	3.11e-05	0.000557	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—rheumatoid arthritis	3.11e-05	0.000557	CcSEcCtD
Pazopanib—Rash—Leflunomide—rheumatoid arthritis	3.11e-05	0.000557	CcSEcCtD
Pazopanib—Dermatitis—Leflunomide—rheumatoid arthritis	3.11e-05	0.000556	CcSEcCtD
Pazopanib—Mental disorder—Prednisone—rheumatoid arthritis	3.11e-05	0.000556	CcSEcCtD
Pazopanib—Nausea—Azathioprine—rheumatoid arthritis	3.11e-05	0.000556	CcSEcCtD
Pazopanib—Headache—Leflunomide—rheumatoid arthritis	3.09e-05	0.000553	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—rheumatoid arthritis	3.09e-05	0.000553	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—rheumatoid arthritis	3.09e-05	0.000552	CcSEcCtD
Pazopanib—Erythema—Prednisone—rheumatoid arthritis	3.09e-05	0.000552	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	3.08e-05	0.000552	CcSEcCtD
Pazopanib—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	3.08e-05	0.000551	CcSEcCtD
Pazopanib—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	3.08e-05	0.00055	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—rheumatoid arthritis	3.06e-05	0.000548	CcSEcCtD
Pazopanib—Hypertension—Dexamethasone—rheumatoid arthritis	3.06e-05	0.000548	CcSEcCtD
Pazopanib—Hypertension—Betamethasone—rheumatoid arthritis	3.06e-05	0.000548	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—rheumatoid arthritis	3.04e-05	0.000544	CcSEcCtD
Pazopanib—Myalgia—Betamethasone—rheumatoid arthritis	3.02e-05	0.00054	CcSEcCtD
Pazopanib—Myalgia—Dexamethasone—rheumatoid arthritis	3.02e-05	0.00054	CcSEcCtD
Pazopanib—Abdominal pain—Cyclosporine—rheumatoid arthritis	3.01e-05	0.000539	CcSEcCtD
Pazopanib—Dyspepsia—Hydrocortisone—rheumatoid arthritis	2.98e-05	0.000533	CcSEcCtD
Pazopanib—Haemoglobin—Methotrexate—rheumatoid arthritis	2.98e-05	0.000533	CcSEcCtD
Pazopanib—Pain—Prednisolone—rheumatoid arthritis	2.96e-05	0.00053	CcSEcCtD
Pazopanib—Haemorrhage—Methotrexate—rheumatoid arthritis	2.96e-05	0.00053	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	2.94e-05	0.000527	CcSEcCtD
Pazopanib—Nausea—Leflunomide—rheumatoid arthritis	2.93e-05	0.000525	CcSEcCtD
Pazopanib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	2.93e-05	0.000524	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	2.92e-05	0.000523	CcSEcCtD
Pazopanib—Fatigue—Hydrocortisone—rheumatoid arthritis	2.92e-05	0.000522	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—rheumatoid arthritis	2.91e-05	0.000521	CcSEcCtD
Pazopanib—Urethral disorder—Methotrexate—rheumatoid arthritis	2.91e-05	0.00052	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	2.9e-05	0.00052	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.9e-05	0.000519	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—rheumatoid arthritis	2.9e-05	0.000518	CcSEcCtD
Pazopanib—Oedema—Dexamethasone—rheumatoid arthritis	2.89e-05	0.000518	CcSEcCtD
Pazopanib—Oedema—Betamethasone—rheumatoid arthritis	2.89e-05	0.000518	CcSEcCtD
Pazopanib—Insomnia—Triamcinolone—rheumatoid arthritis	2.88e-05	0.000516	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—rheumatoid arthritis	2.88e-05	0.000515	CcSEcCtD
Pazopanib—Infection—Betamethasone—rheumatoid arthritis	2.87e-05	0.000514	CcSEcCtD
Pazopanib—Infection—Dexamethasone—rheumatoid arthritis	2.87e-05	0.000514	CcSEcCtD
Pazopanib—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.86e-05	0.000512	CcSEcCtD
Pazopanib—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.86e-05	0.000511	CcSEcCtD
Pazopanib—Anaemia—Prednisone—rheumatoid arthritis	2.85e-05	0.00051	CcSEcCtD
Pazopanib—Shock—Betamethasone—rheumatoid arthritis	2.85e-05	0.000509	CcSEcCtD
Pazopanib—Shock—Dexamethasone—rheumatoid arthritis	2.85e-05	0.000509	CcSEcCtD
Pazopanib—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.84e-05	0.000509	CcSEcCtD
Pazopanib—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.84e-05	0.000508	CcSEcCtD
Pazopanib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.84e-05	0.000508	CcSEcCtD
Pazopanib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	2.83e-05	0.000507	CcSEcCtD
Pazopanib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	2.83e-05	0.000507	CcSEcCtD
Pazopanib—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.81e-05	0.000502	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.8e-05	0.000501	CcSEcCtD
Pazopanib—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.8e-05	0.0005	CcSEcCtD
Pazopanib—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.8e-05	0.0005	CcSEcCtD
Pazopanib—Eye disorder—Methotrexate—rheumatoid arthritis	2.77e-05	0.000496	CcSEcCtD
Pazopanib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.77e-05	0.000495	CcSEcCtD
Pazopanib—Syncope—Prednisone—rheumatoid arthritis	2.77e-05	0.000495	CcSEcCtD
Pazopanib—Anorexia—Dexamethasone—rheumatoid arthritis	2.76e-05	0.000493	CcSEcCtD
Pazopanib—Anorexia—Betamethasone—rheumatoid arthritis	2.76e-05	0.000493	CcSEcCtD
Pazopanib—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.75e-05	0.000492	CcSEcCtD
Pazopanib—Fatigue—Triamcinolone—rheumatoid arthritis	2.75e-05	0.000492	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—rheumatoid arthritis	2.74e-05	0.000491	CcSEcCtD
Pazopanib—Asthenia—Cyclosporine—rheumatoid arthritis	2.73e-05	0.000489	CcSEcCtD
Pazopanib—Pain—Triamcinolone—rheumatoid arthritis	2.73e-05	0.000488	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisone—rheumatoid arthritis	2.71e-05	0.000485	CcSEcCtD
Pazopanib—Pruritus—Cyclosporine—rheumatoid arthritis	2.7e-05	0.000482	CcSEcCtD
Pazopanib—Angiopathy—Methotrexate—rheumatoid arthritis	2.69e-05	0.000481	CcSEcCtD
Pazopanib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.68e-05	0.000479	CcSEcCtD
Pazopanib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.67e-05	0.000478	CcSEcCtD
Pazopanib—Hypertension—Prednisone—rheumatoid arthritis	2.67e-05	0.000477	CcSEcCtD
Pazopanib—Chills—Methotrexate—rheumatoid arthritis	2.66e-05	0.000476	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.64e-05	0.000472	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.64e-05	0.000472	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—rheumatoid arthritis	2.63e-05	0.00047	CcSEcCtD
Pazopanib—Myalgia—Prednisone—rheumatoid arthritis	2.63e-05	0.00047	CcSEcCtD
Pazopanib—Alopecia—Methotrexate—rheumatoid arthritis	2.62e-05	0.000469	CcSEcCtD
Pazopanib—Insomnia—Dexamethasone—rheumatoid arthritis	2.62e-05	0.000468	CcSEcCtD
Pazopanib—Insomnia—Betamethasone—rheumatoid arthritis	2.62e-05	0.000468	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.61e-05	0.000467	CcSEcCtD
Pazopanib—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.61e-05	0.000466	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.6e-05	0.000465	CcSEcCtD
Pazopanib—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.6e-05	0.000465	CcSEcCtD
Pazopanib—Paraesthesia—Betamethasone—rheumatoid arthritis	2.6e-05	0.000465	CcSEcCtD
Pazopanib—Mental disorder—Methotrexate—rheumatoid arthritis	2.6e-05	0.000465	CcSEcCtD
Pazopanib—Erythema—Methotrexate—rheumatoid arthritis	2.58e-05	0.000462	CcSEcCtD
Pazopanib—Malnutrition—Methotrexate—rheumatoid arthritis	2.58e-05	0.000462	CcSEcCtD
Pazopanib—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.55e-05	0.000456	CcSEcCtD
Pazopanib—Dyspepsia—Betamethasone—rheumatoid arthritis	2.55e-05	0.000456	CcSEcCtD
Pazopanib—Dysgeusia—Methotrexate—rheumatoid arthritis	2.53e-05	0.000452	CcSEcCtD
Pazopanib—Dizziness—Cyclosporine—rheumatoid arthritis	2.52e-05	0.000451	CcSEcCtD
Pazopanib—Oedema—Prednisone—rheumatoid arthritis	2.52e-05	0.000451	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.51e-05	0.00045	CcSEcCtD
Pazopanib—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.51e-05	0.00045	CcSEcCtD
Pazopanib—Decreased appetite—Betamethasone—rheumatoid arthritis	2.51e-05	0.00045	CcSEcCtD
Pazopanib—Infection—Prednisone—rheumatoid arthritis	2.5e-05	0.000448	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.5e-05	0.000447	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.5e-05	0.000447	CcSEcCtD
Pazopanib—Fatigue—Betamethasone—rheumatoid arthritis	2.49e-05	0.000446	CcSEcCtD
Pazopanib—Fatigue—Dexamethasone—rheumatoid arthritis	2.49e-05	0.000446	CcSEcCtD
Pazopanib—Shock—Prednisone—rheumatoid arthritis	2.48e-05	0.000443	CcSEcCtD
Pazopanib—Pain—Dexamethasone—rheumatoid arthritis	2.47e-05	0.000443	CcSEcCtD
Pazopanib—Pain—Betamethasone—rheumatoid arthritis	2.47e-05	0.000443	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—rheumatoid arthritis	2.47e-05	0.000442	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—rheumatoid arthritis	2.45e-05	0.000438	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.44e-05	0.000436	CcSEcCtD
Pazopanib—Vision blurred—Methotrexate—rheumatoid arthritis	2.43e-05	0.000435	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—rheumatoid arthritis	2.43e-05	0.000435	CcSEcCtD
Pazopanib—Vomiting—Cyclosporine—rheumatoid arthritis	2.42e-05	0.000433	CcSEcCtD
Pazopanib—Rash—Cyclosporine—rheumatoid arthritis	2.4e-05	0.00043	CcSEcCtD
Pazopanib—Anorexia—Prednisone—rheumatoid arthritis	2.4e-05	0.00043	CcSEcCtD
Pazopanib—Dermatitis—Cyclosporine—rheumatoid arthritis	2.4e-05	0.000429	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—rheumatoid arthritis	2.4e-05	0.000429	CcSEcCtD
Pazopanib—Headache—Cyclosporine—rheumatoid arthritis	2.39e-05	0.000427	CcSEcCtD
Pazopanib—Anaemia—Methotrexate—rheumatoid arthritis	2.38e-05	0.000427	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.37e-05	0.000423	CcSEcCtD
Pazopanib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.37e-05	0.000423	CcSEcCtD
Pazopanib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.32e-05	0.000415	CcSEcCtD
Pazopanib—Leukopenia—Methotrexate—rheumatoid arthritis	2.31e-05	0.000413	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.3e-05	0.000411	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—rheumatoid arthritis	2.29e-05	0.00041	CcSEcCtD
Pazopanib—Asthenia—Triamcinolone—rheumatoid arthritis	2.29e-05	0.000409	CcSEcCtD
Pazopanib—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.29e-05	0.000409	CcSEcCtD
Pazopanib—Abdominal pain—Betamethasone—rheumatoid arthritis	2.29e-05	0.000409	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—rheumatoid arthritis	2.28e-05	0.000408	CcSEcCtD
Pazopanib—Insomnia—Prednisone—rheumatoid arthritis	2.28e-05	0.000408	CcSEcCtD
Pazopanib—Nausea—Cyclosporine—rheumatoid arthritis	2.26e-05	0.000405	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—rheumatoid arthritis	2.26e-05	0.000405	CcSEcCtD
Pazopanib—Pruritus—Triamcinolone—rheumatoid arthritis	2.26e-05	0.000404	CcSEcCtD
Pazopanib—Cough—Methotrexate—rheumatoid arthritis	2.25e-05	0.000403	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—rheumatoid arthritis	2.25e-05	0.000403	CcSEcCtD
Pazopanib—Dizziness—Hydrocortisone—rheumatoid arthritis	2.24e-05	0.000401	CcSEcCtD
Pazopanib—Dyspepsia—Prednisone—rheumatoid arthritis	2.22e-05	0.000397	CcSEcCtD
Pazopanib—Arthralgia—Methotrexate—rheumatoid arthritis	2.2e-05	0.000393	CcSEcCtD
Pazopanib—Myalgia—Methotrexate—rheumatoid arthritis	2.2e-05	0.000393	CcSEcCtD
Pazopanib—Chest pain—Methotrexate—rheumatoid arthritis	2.2e-05	0.000393	CcSEcCtD
Pazopanib—Decreased appetite—Prednisone—rheumatoid arthritis	2.19e-05	0.000392	CcSEcCtD
Pazopanib—Rash—Prednisolone—rheumatoid arthritis	2.19e-05	0.000391	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—rheumatoid arthritis	2.18e-05	0.000391	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.18e-05	0.00039	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.18e-05	0.000389	CcSEcCtD
Pazopanib—Fatigue—Prednisone—rheumatoid arthritis	2.17e-05	0.000389	CcSEcCtD
Pazopanib—Headache—Prednisolone—rheumatoid arthritis	2.17e-05	0.000389	CcSEcCtD
Pazopanib—Vomiting—Hydrocortisone—rheumatoid arthritis	2.15e-05	0.000385	CcSEcCtD
Pazopanib—Rash—Hydrocortisone—rheumatoid arthritis	2.13e-05	0.000382	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.13e-05	0.000382	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—rheumatoid arthritis	2.12e-05	0.00038	CcSEcCtD
Pazopanib—Dizziness—Triamcinolone—rheumatoid arthritis	2.11e-05	0.000377	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—rheumatoid arthritis	2.1e-05	0.000376	CcSEcCtD
Pazopanib—Infection—Methotrexate—rheumatoid arthritis	2.09e-05	0.000374	CcSEcCtD
Pazopanib—Asthenia—Dexamethasone—rheumatoid arthritis	2.08e-05	0.000371	CcSEcCtD
Pazopanib—Asthenia—Betamethasone—rheumatoid arthritis	2.08e-05	0.000371	CcSEcCtD
Pazopanib—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.06e-05	0.000369	CcSEcCtD
Pazopanib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.06e-05	0.000369	CcSEcCtD
Pazopanib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.06e-05	0.000369	CcSEcCtD
Pazopanib—Nausea—Prednisolone—rheumatoid arthritis	2.06e-05	0.000368	CcSEcCtD
Pazopanib—Pruritus—Dexamethasone—rheumatoid arthritis	2.05e-05	0.000366	CcSEcCtD
Pazopanib—Pruritus—Betamethasone—rheumatoid arthritis	2.05e-05	0.000366	CcSEcCtD
Pazopanib—Skin disorder—Methotrexate—rheumatoid arthritis	2.05e-05	0.000366	CcSEcCtD
Pazopanib—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.04e-05	0.000364	CcSEcCtD
Pazopanib—Vomiting—Triamcinolone—rheumatoid arthritis	2.03e-05	0.000363	CcSEcCtD
Pazopanib—Vomiting—Methylprednisolone—rheumatoid arthritis	2.02e-05	0.000362	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—rheumatoid arthritis	2.01e-05	0.00036	CcSEcCtD
Pazopanib—Rash—Triamcinolone—rheumatoid arthritis	2.01e-05	0.00036	CcSEcCtD
Pazopanib—Dermatitis—Triamcinolone—rheumatoid arthritis	2.01e-05	0.000359	CcSEcCtD
Pazopanib—Anorexia—Methotrexate—rheumatoid arthritis	2.01e-05	0.000359	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—rheumatoid arthritis	2.01e-05	0.000359	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—rheumatoid arthritis	2e-05	0.000359	CcSEcCtD
Pazopanib—Headache—Triamcinolone—rheumatoid arthritis	2e-05	0.000357	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—rheumatoid arthritis	1.99e-05	0.000357	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—rheumatoid arthritis	1.99e-05	0.000356	CcSEcCtD
Pazopanib—Diarrhoea—Betamethasone—rheumatoid arthritis	1.98e-05	0.000354	CcSEcCtD
Pazopanib—Diarrhoea—Dexamethasone—rheumatoid arthritis	1.98e-05	0.000354	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.92e-05	0.000343	CcSEcCtD
Pazopanib—Dizziness—Betamethasone—rheumatoid arthritis	1.91e-05	0.000342	CcSEcCtD
Pazopanib—Dizziness—Dexamethasone—rheumatoid arthritis	1.91e-05	0.000342	CcSEcCtD
Pazopanib—Insomnia—Methotrexate—rheumatoid arthritis	1.9e-05	0.000341	CcSEcCtD
Pazopanib—Nausea—Triamcinolone—rheumatoid arthritis	1.89e-05	0.000339	CcSEcCtD
Pazopanib—Paraesthesia—Methotrexate—rheumatoid arthritis	1.89e-05	0.000338	CcSEcCtD
Pazopanib—Nausea—Methylprednisolone—rheumatoid arthritis	1.89e-05	0.000338	CcSEcCtD
Pazopanib—Dyspnoea—Methotrexate—rheumatoid arthritis	1.88e-05	0.000336	CcSEcCtD
Pazopanib—Somnolence—Methotrexate—rheumatoid arthritis	1.87e-05	0.000335	CcSEcCtD
Pazopanib—Dyspepsia—Methotrexate—rheumatoid arthritis	1.85e-05	0.000332	CcSEcCtD
Pazopanib—Vomiting—Dexamethasone—rheumatoid arthritis	1.84e-05	0.000329	CcSEcCtD
Pazopanib—Vomiting—Betamethasone—rheumatoid arthritis	1.84e-05	0.000329	CcSEcCtD
Pazopanib—Decreased appetite—Methotrexate—rheumatoid arthritis	1.83e-05	0.000327	CcSEcCtD
Pazopanib—Rash—Dexamethasone—rheumatoid arthritis	1.82e-05	0.000326	CcSEcCtD
Pazopanib—Rash—Betamethasone—rheumatoid arthritis	1.82e-05	0.000326	CcSEcCtD
Pazopanib—Dermatitis—Dexamethasone—rheumatoid arthritis	1.82e-05	0.000326	CcSEcCtD
Pazopanib—Dermatitis—Betamethasone—rheumatoid arthritis	1.82e-05	0.000326	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.82e-05	0.000325	CcSEcCtD
Pazopanib—Fatigue—Methotrexate—rheumatoid arthritis	1.82e-05	0.000325	CcSEcCtD
Pazopanib—Headache—Betamethasone—rheumatoid arthritis	1.81e-05	0.000324	CcSEcCtD
Pazopanib—Headache—Dexamethasone—rheumatoid arthritis	1.81e-05	0.000324	CcSEcCtD
Pazopanib—Asthenia—Prednisone—rheumatoid arthritis	1.81e-05	0.000323	CcSEcCtD
Pazopanib—Pain—Methotrexate—rheumatoid arthritis	1.8e-05	0.000322	CcSEcCtD
Pazopanib—Pruritus—Prednisone—rheumatoid arthritis	1.78e-05	0.000319	CcSEcCtD
Pazopanib—Diarrhoea—Prednisone—rheumatoid arthritis	1.72e-05	0.000308	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.72e-05	0.000308	CcSEcCtD
Pazopanib—Nausea—Dexamethasone—rheumatoid arthritis	1.72e-05	0.000307	CcSEcCtD
Pazopanib—Nausea—Betamethasone—rheumatoid arthritis	1.72e-05	0.000307	CcSEcCtD
Pazopanib—Dizziness—Prednisone—rheumatoid arthritis	1.67e-05	0.000298	CcSEcCtD
Pazopanib—Abdominal pain—Methotrexate—rheumatoid arthritis	1.66e-05	0.000298	CcSEcCtD
Pazopanib—Vomiting—Prednisone—rheumatoid arthritis	1.6e-05	0.000287	CcSEcCtD
Pazopanib—Rash—Prednisone—rheumatoid arthritis	1.59e-05	0.000284	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—rheumatoid arthritis	1.59e-05	0.000284	CcSEcCtD
Pazopanib—Headache—Prednisone—rheumatoid arthritis	1.58e-05	0.000282	CcSEcCtD
Pazopanib—Asthenia—Methotrexate—rheumatoid arthritis	1.51e-05	0.00027	CcSEcCtD
Pazopanib—Nausea—Prednisone—rheumatoid arthritis	1.5e-05	0.000268	CcSEcCtD
Pazopanib—Pruritus—Methotrexate—rheumatoid arthritis	1.49e-05	0.000267	CcSEcCtD
Pazopanib—Diarrhoea—Methotrexate—rheumatoid arthritis	1.44e-05	0.000258	CcSEcCtD
Pazopanib—Dizziness—Methotrexate—rheumatoid arthritis	1.39e-05	0.000249	CcSEcCtD
Pazopanib—Vomiting—Methotrexate—rheumatoid arthritis	1.34e-05	0.00024	CcSEcCtD
Pazopanib—Rash—Methotrexate—rheumatoid arthritis	1.33e-05	0.000238	CcSEcCtD
Pazopanib—Dermatitis—Methotrexate—rheumatoid arthritis	1.33e-05	0.000237	CcSEcCtD
Pazopanib—Headache—Methotrexate—rheumatoid arthritis	1.32e-05	0.000236	CcSEcCtD
Pazopanib—Nausea—Methotrexate—rheumatoid arthritis	1.25e-05	0.000224	CcSEcCtD
Pazopanib—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	8.96e-07	1.17e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTK2—rheumatoid arthritis	8.96e-07	1.17e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—rheumatoid arthritis	8.89e-07	1.16e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—rheumatoid arthritis	8.84e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—rheumatoid arthritis	8.84e-07	1.15e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCL2—rheumatoid arthritis	8.84e-07	1.15e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—rheumatoid arthritis	8.84e-07	1.15e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6R—rheumatoid arthritis	8.81e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—rheumatoid arthritis	8.81e-07	1.15e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL5—rheumatoid arthritis	8.78e-07	1.15e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—LEP—rheumatoid arthritis	8.78e-07	1.15e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—PTGS2—rheumatoid arthritis	8.78e-07	1.14e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—rheumatoid arthritis	8.7e-07	1.14e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—TP53—rheumatoid arthritis	8.66e-07	1.13e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—rheumatoid arthritis	8.66e-07	1.13e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CSF2—rheumatoid arthritis	8.65e-07	1.13e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—rheumatoid arthritis	8.63e-07	1.13e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—rheumatoid arthritis	8.61e-07	1.12e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6R—rheumatoid arthritis	8.61e-07	1.12e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CXCL8—rheumatoid arthritis	8.6e-07	1.12e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—BGN—rheumatoid arthritis	8.58e-07	1.12e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—POMC—rheumatoid arthritis	8.57e-07	1.12e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—POMC—rheumatoid arthritis	8.55e-07	1.12e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—TYK2—rheumatoid arthritis	8.5e-07	1.11e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—FN1—rheumatoid arthritis	8.46e-07	1.1e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—POMC—rheumatoid arthritis	8.44e-07	1.1e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6ST—rheumatoid arthritis	8.42e-07	1.1e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—VEGFA—rheumatoid arthritis	8.4e-07	1.1e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL2—rheumatoid arthritis	8.39e-07	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL2—rheumatoid arthritis	8.37e-07	1.09e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MMP9—rheumatoid arthritis	8.37e-07	1.09e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6R—rheumatoid arthritis	8.36e-07	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6R—rheumatoid arthritis	8.34e-07	1.09e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—TP53—rheumatoid arthritis	8.31e-07	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—rheumatoid arthritis	8.3e-07	1.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—FN1—rheumatoid arthritis	8.28e-07	1.08e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NFKB1—rheumatoid arthritis	8.28e-07	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NFKB1—rheumatoid arthritis	8.25e-07	1.08e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6ST—rheumatoid arthritis	8.25e-07	1.08e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—rheumatoid arthritis	8.22e-07	1.07e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TYK2—rheumatoid arthritis	8.17e-07	1.07e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MMP9—rheumatoid arthritis	8.15e-07	1.06e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MAPK8—rheumatoid arthritis	8.14e-07	1.06e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SPP1—rheumatoid arthritis	8.13e-07	1.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—MAPK8—rheumatoid arthritis	8.11e-07	1.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CD80—rheumatoid arthritis	8.11e-07	1.06e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—NFKB1—rheumatoid arthritis	8.08e-07	1.05e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NFKB1—rheumatoid arthritis	8.07e-07	1.05e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	8.06e-07	1.05e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TYK2—rheumatoid arthritis	8.03e-07	1.05e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NOS3—rheumatoid arthritis	8.02e-07	1.05e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	7.96e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—rheumatoid arthritis	7.96e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—MAPK8—rheumatoid arthritis	7.94e-07	1.04e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CD80—rheumatoid arthritis	7.94e-07	1.04e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MAPK8—rheumatoid arthritis	7.93e-07	1.03e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—rheumatoid arthritis	7.91e-07	1.03e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	7.91e-07	1.03e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	7.89e-07	1.03e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NOS3—rheumatoid arthritis	7.88e-07	1.03e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TYK2—rheumatoid arthritis	7.85e-07	1.02e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2RA—rheumatoid arthritis	7.8e-07	1.02e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MMP9—rheumatoid arthritis	7.78e-07	1.01e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—POMC—rheumatoid arthritis	7.74e-07	1.01e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—C3—rheumatoid arthritis	7.73e-07	1.01e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TGFB1—rheumatoid arthritis	7.71e-07	1.01e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—POMC—rheumatoid arthritis	7.7e-07	1.01e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—NOS3—rheumatoid arthritis	7.7e-07	1e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—ALB—rheumatoid arthritis	7.7e-07	1e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NFKB1—rheumatoid arthritis	7.7e-07	1e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—rheumatoid arthritis	7.68e-07	1e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TYK2—rheumatoid arthritis	7.62e-07	9.94e-06	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—rheumatoid arthritis	7.61e-07	9.93e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TYK2—rheumatoid arthritis	7.6e-07	9.91e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	7.6e-07	9.91e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—rheumatoid arthritis	7.58e-07	9.88e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MAPK8—rheumatoid arthritis	7.56e-07	9.87e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—rheumatoid arthritis	7.54e-07	9.84e-06	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	7.54e-07	9.84e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—rheumatoid arthritis	7.54e-07	9.84e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6R—rheumatoid arthritis	7.52e-07	9.81e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—rheumatoid arthritis	7.51e-07	9.8e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—rheumatoid arthritis	7.48e-07	9.76e-06	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—rheumatoid arthritis	7.47e-07	9.75e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—rheumatoid arthritis	7.46e-07	9.73e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—rheumatoid arthritis	7.44e-07	9.71e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—rheumatoid arthritis	7.38e-07	9.63e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—rheumatoid arthritis	7.36e-07	9.61e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6R—rheumatoid arthritis	7.36e-07	9.6e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	7.35e-07	9.59e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	7.35e-07	9.59e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—rheumatoid arthritis	7.32e-07	9.55e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEP—rheumatoid arthritis	7.2e-07	9.39e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—rheumatoid arthritis	7.16e-07	9.35e-06	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—rheumatoid arthritis	7.14e-07	9.31e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL8—rheumatoid arthritis	7.12e-07	9.28e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—rheumatoid arthritis	7.1e-07	9.26e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—rheumatoid arthritis	7.09e-07	9.26e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—rheumatoid arthritis	7.07e-07	9.22e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—rheumatoid arthritis	7.06e-07	9.21e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—rheumatoid arthritis	7.05e-07	9.2e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—rheumatoid arthritis	7.04e-07	9.19e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—rheumatoid arthritis	7.04e-07	9.19e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL8—rheumatoid arthritis	6.99e-07	9.12e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—rheumatoid arthritis	6.98e-07	9.11e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	6.94e-07	9.06e-06	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—rheumatoid arthritis	6.9e-07	9e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—rheumatoid arthritis	6.9e-07	9e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	6.85e-07	8.93e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—rheumatoid arthritis	6.8e-07	8.87e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FN1—rheumatoid arthritis	6.79e-07	8.86e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6ST—rheumatoid arthritis	6.76e-07	8.82e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—rheumatoid arthritis	6.75e-07	8.8e-06	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—rheumatoid arthritis	6.73e-07	8.79e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—rheumatoid arthritis	6.72e-07	8.77e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	6.72e-07	8.77e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TYK2—rheumatoid arthritis	6.7e-07	8.74e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—rheumatoid arthritis	6.68e-07	8.71e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAT—rheumatoid arthritis	6.66e-07	8.69e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL8—rheumatoid arthritis	6.63e-07	8.65e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—NFKB1—rheumatoid arthritis	6.62e-07	8.64e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	6.62e-07	8.64e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL8—rheumatoid arthritis	6.62e-07	8.63e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—rheumatoid arthritis	6.58e-07	8.58e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—rheumatoid arthritis	6.53e-07	8.52e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK8—rheumatoid arthritis	6.51e-07	8.49e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CD80—rheumatoid arthritis	6.51e-07	8.49e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—rheumatoid arthritis	6.44e-07	8.4e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	6.44e-07	8.4e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—rheumatoid arthritis	6.41e-07	8.36e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NFKB1—rheumatoid arthritis	6.37e-07	8.31e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—TP53—rheumatoid arthritis	6.35e-07	8.28e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	6.34e-07	8.28e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—rheumatoid arthritis	6.34e-07	8.27e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	6.33e-07	8.26e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—rheumatoid arthritis	6.32e-07	8.25e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—rheumatoid arthritis	6.32e-07	8.25e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK8—rheumatoid arthritis	6.26e-07	8.17e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NFKB1—rheumatoid arthritis	6.25e-07	8.16e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	6.25e-07	8.15e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—rheumatoid arthritis	6.18e-07	8.07e-06	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—rheumatoid arthritis	6.18e-07	8.07e-06	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—rheumatoid arthritis	6.17e-07	8.05e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK8—rheumatoid arthritis	6.15e-07	8.02e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	6.09e-07	7.95e-06	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—rheumatoid arthritis	6.07e-07	7.92e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—rheumatoid arthritis	6.05e-07	7.89e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6R—rheumatoid arthritis	6.03e-07	7.87e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—rheumatoid arthritis	6e-07	7.83e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—rheumatoid arthritis	5.98e-07	7.81e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	5.96e-07	7.78e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NFKB1—rheumatoid arthritis	5.94e-07	7.74e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NFKB1—rheumatoid arthritis	5.92e-07	7.72e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—rheumatoid arthritis	5.84e-07	7.61e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK8—rheumatoid arthritis	5.83e-07	7.61e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK8—rheumatoid arthritis	5.82e-07	7.59e-06	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—rheumatoid arthritis	5.81e-07	7.58e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—rheumatoid arthritis	5.8e-07	7.57e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—rheumatoid arthritis	5.78e-07	7.54e-06	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—rheumatoid arthritis	5.76e-07	7.52e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—rheumatoid arthritis	5.75e-07	7.5e-06	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	5.71e-07	7.45e-06	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—rheumatoid arthritis	5.71e-07	7.45e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	5.7e-07	7.43e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—rheumatoid arthritis	5.68e-07	7.41e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TP53—rheumatoid arthritis	5.68e-07	7.41e-06	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—rheumatoid arthritis	5.61e-07	7.31e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—rheumatoid arthritis	5.58e-07	7.28e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—MTHFR—rheumatoid arthritis	5.56e-07	7.25e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	5.54e-07	7.22e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TP53—rheumatoid arthritis	5.53e-07	7.22e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TYK2—rheumatoid arthritis	5.49e-07	7.17e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	5.47e-07	7.13e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—rheumatoid arthritis	5.39e-07	7.04e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	5.39e-07	7.03e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—rheumatoid arthritis	5.39e-07	7.03e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—rheumatoid arthritis	5.37e-07	7.01e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	5.33e-07	6.96e-06	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—rheumatoid arthritis	5.32e-07	6.94e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—rheumatoid arthritis	5.31e-07	6.92e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—rheumatoid arthritis	5.31e-07	6.92e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—rheumatoid arthritis	5.28e-07	6.89e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TP53—rheumatoid arthritis	5.28e-07	6.88e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	5.24e-07	6.84e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NFKB1—rheumatoid arthritis	5.22e-07	6.81e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—rheumatoid arthritis	5.21e-07	6.8e-06	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—rheumatoid arthritis	5.2e-07	6.78e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—rheumatoid arthritis	5.18e-07	6.76e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK8—rheumatoid arthritis	5.13e-07	6.7e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—rheumatoid arthritis	5.09e-07	6.64e-06	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—rheumatoid arthritis	5.07e-07	6.61e-06	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—rheumatoid arthritis	5.06e-07	6.61e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	4.97e-07	6.48e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—rheumatoid arthritis	4.94e-07	6.45e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—rheumatoid arthritis	4.93e-07	6.43e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	4.84e-07	6.32e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	4.84e-07	6.32e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—rheumatoid arthritis	4.83e-07	6.3e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—rheumatoid arthritis	4.78e-07	6.24e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—rheumatoid arthritis	4.78e-07	6.24e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—rheumatoid arthritis	4.74e-07	6.18e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	4.63e-07	6.04e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—rheumatoid arthritis	4.57e-07	5.96e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	4.56e-07	5.95e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—rheumatoid arthritis	4.45e-07	5.8e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	4.44e-07	5.8e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TP53—rheumatoid arthritis	4.37e-07	5.7e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—rheumatoid arthritis	4.35e-07	5.68e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—rheumatoid arthritis	4.33e-07	5.64e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TP53—rheumatoid arthritis	4.29e-07	5.6e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NFKB1—rheumatoid arthritis	4.28e-07	5.58e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK8—rheumatoid arthritis	4.21e-07	5.49e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—rheumatoid arthritis	4.16e-07	5.42e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TP53—rheumatoid arthritis	4.07e-07	5.31e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TP53—rheumatoid arthritis	4.06e-07	5.3e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—rheumatoid arthritis	4.05e-07	5.29e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—rheumatoid arthritis	4e-07	5.22e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—rheumatoid arthritis	3.93e-07	5.12e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—rheumatoid arthritis	3.88e-07	5.07e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—rheumatoid arthritis	3.88e-07	5.06e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—rheumatoid arthritis	3.87e-07	5.05e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	3.87e-07	5.04e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—rheumatoid arthritis	3.84e-07	5.01e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—rheumatoid arthritis	3.73e-07	4.86e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—rheumatoid arthritis	3.72e-07	4.85e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	3.66e-07	4.77e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	3.65e-07	4.76e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TP53—rheumatoid arthritis	3.58e-07	4.67e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	3.57e-07	4.66e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—rheumatoid arthritis	3.57e-07	4.65e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—rheumatoid arthritis	3.55e-07	4.63e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—rheumatoid arthritis	3.53e-07	4.61e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	3.38e-07	4.41e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	3.35e-07	4.37e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	3.33e-07	4.34e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—rheumatoid arthritis	3.28e-07	4.28e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	3.18e-07	4.15e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	3.09e-07	4.03e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	3.09e-07	4.03e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	2.98e-07	3.89e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TP53—rheumatoid arthritis	2.94e-07	3.83e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	2.91e-07	3.8e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	2.82e-07	3.68e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	2.7e-07	3.52e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—rheumatoid arthritis	2.69e-07	3.51e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	2.47e-07	3.22e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	2.39e-07	3.11e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	2.18e-07	2.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	2.08e-07	2.72e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	1.9e-07	2.48e-06	CbGpPWpGaD
